Repro Med Systems Stock Performance
| KRMD Stock | USD 3.37 0.07 2.12% |
On a scale of 0 to 100, Repro Med holds a performance score of 12. The company holds a Beta of -0.49, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Repro Med are expected to decrease at a much lower rate. During the bear market, Repro Med is likely to outperform the market. Please check Repro Med's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Repro Med's historical price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Repro Med Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Repro Med exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 11.5 M | |
| Total Cashflows From Investing Activities | -1.3 M | |
| Free Cash Flow | -1.6 M |
Repro Med Relative Risk vs. Return Landscape
If you would invest 224.00 in Repro Med Systems on April 21, 2025 and sell it today you would earn a total of 113.00 from holding Repro Med Systems or generate 50.45% return on investment over 90 days. Repro Med Systems is currently generating 0.7491% in daily expected returns and assumes 4.5656% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Repro, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Repro Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Repro Med's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Repro Med Systems, and traders can use it to determine the average amount a Repro Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1641
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.57 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.75 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Repro Med is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Repro Med by adding it to a well-diversified portfolio.
Repro Med Fundamentals Growth
Repro Stock prices reflect investors' perceptions of the future prospects and financial health of Repro Med, and Repro Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Repro Stock performance.
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 150.49 M | ||||
| Shares Outstanding | 46.14 M | ||||
| Price To Earning | 11.56 X | ||||
| Price To Book | 9.51 X | ||||
| Price To Sales | 4.43 X | ||||
| Revenue | 33.65 M | ||||
| EBITDA | (5.56 M) | ||||
| Cash And Equivalents | 18.27 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 3.99 M | ||||
| Debt To Equity | 0.14 % | ||||
| Book Value Per Share | 0.35 X | ||||
| Cash Flow From Operations | (319.72 K) | ||||
| Earnings Per Share | (0.12) X | ||||
| Total Asset | 27.22 M | ||||
| Retained Earnings | (29.38 M) | ||||
| Current Asset | 2.54 M | ||||
| Current Liabilities | 516.46 K | ||||
About Repro Med Performance
By analyzing Repro Med's fundamental ratios, stakeholders can gain valuable insights into Repro Med's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Repro Med has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Repro Med has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York. Koru Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.Things to note about Repro Med Systems performance evaluation
Checking the ongoing alerts about Repro Med for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Repro Med Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Repro Med Systems appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 33.65 M. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 22.27 M. | |
| Repro Med Systems currently holds about 18.27 M in cash with (319.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. |
- Analyzing Repro Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Repro Med's stock is overvalued or undervalued compared to its peers.
- Examining Repro Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Repro Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Repro Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Repro Med's stock. These opinions can provide insight into Repro Med's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |